The Executional Excellence issue of Perspective magazine is live

Blue Latitude Health | 23rd May 2017

Blue Latitude Health has spent 14 years building a truly world-class creative marketing consultancy. Combining the best of consultancy and agency to solve the most complex of healthcare challenges at a brand, portfolio and organisational level. 

What drives us at BLH is the opportunity to make a real difference – and for our clients, that difference is measured both in customer outcomes and commercial outcomes. Creating work that stands out is important, but creating work that delivers results is imperative. In this edition, we explore topics around the ‘executional excellence’ theme – creating work that works. 

Read more about:

  • How to plan and execute the perfect congress experience
  • How to find that global sweet spot - international creative work that works 
  • What an EMEA Marketing Lead at Janssen looks for in an exceptional creative campaign 
  • How global organisations can improve the localisation of digital services in pharma 
  • How we created a properly integrated full-service global team by baking in creative services to our consultancy approach. 

Click the button below to enter your details and receive your free digital copy.

Achieving deep understanding of healthcare customer behaviour

Martine Leroy | 18th October 2017

In part one of a series on customer insight and behaviour change, Martine Leroy reveals a behaviour framework for gathering sharp insights used to help brand managers and marketers achieve their business goals and create a customer-centric strategy. 

read more

How do you define a biotech company?

David Cooney | 6th October 2017

We ask if the defnition of biotech needs updating as big pharma turns its research and development aims to biological therapies.

read more

Emerging technologies in biotech

Ditte Funding, Natasha Cowan | 25th September 2017

Associate Consultant Ditte Funding and Content Marketing Executive Natasha Cowan explore the transformative technologies revolutionising the biotech industry, from CAR-T to CRISPR.

read more